Trials / Completed
CompletedNCT03484260
Association Between the Prevalence of Cardiovascular Risk Factors and New Use of Testosterone
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 27,778 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We will investigate if testosterone is preferentially given to patients at higher risk of cardiovascular events. If this is the case, then observational studies may be prone to selection bias resulting in overestimation of the cardiovascular risk associated with testosterone when compared to a healthier population not taking testosterone
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Testosterone Product | Men used testosterone product following prescription |
Timeline
- Start date
- 2018-04-01
- Primary completion
- 2018-05-15
- Completion
- 2018-05-15
- First posted
- 2018-03-30
- Last updated
- 2019-05-14
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03484260. Inclusion in this directory is not an endorsement.